FDA, States Start Compounding Pharmacy Discussion
The Food and Drug Administration conferred with public health officials from 50 states for the first time about how best to strengthen rules governing compounding pharmacies in the wake of a national meningitis outbreak caused by a tainted pain medication produced by a Massachusetts pharmacy.
The Food and Drug Administration conferred with public health officials from 50 states for the first time about how best to strengthen rules governing compounding pharmacies in the wake of a national meningitis outbreak caused by a tainted pain medication produced by a Massachusetts pharmacy.
